Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.
(CNSX:MOOD.CN),(Pinksheets:DOSEF),(PinkSheets:DOSEF),(Boerse Frankfurt – Freiverkehr:VU70), KELOWNA, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that its wholly owned Florida subsidiary, Doseology USA Inc., has executed a confidential manufacturing agreement with a […]